ALA — Arovella Therapeutics Balance Sheet

0.000.00%

Last trade - 00:00

HealthcareAdventurousMicro CapFalling Star

Annual balance sheet for Arovella Therapeutics, fiscal year end - June 30th, AUD millions except per share, conversion factor applied.

	2022 June 30th	2023 June 30th	2024 June 30th	2025 June 30th	2026 June 30th
Period Length:	12 M	12 M	12 M	12 M	12 M
Source:	ARS	ARS	ARS	ARS	ARS
Standards:	IFRS	IFRS	IFRS	IFRS	IFRS
Status:	Final	Final	Final	Final	Final
Cash and Equivalents
Cash and Short Term Investments	6.07	5.18	12.7	20.9	14.4
Net Total Accounts Receivable
Net Total Receivables	0.036	0.01	0.175	0.113	0.104
Prepaid Expenses
Total Other Current Assets
Total Current Assets	6.59	5.42	13.2	21.2	14.7
Gross Property, Plant And Equipment
Accumulated Depreciation
Net Property, Plant And Equipment	0.371	0.05	0.131	0.431	0.352
Net Intangible Assets
Total Assets	9.21	5.47	13.3	21.6	15
Accounts Payable
Payable / Accrued
Notes Payable / Short Term Debt
Current Portion of Long Term Debt / Capital Leases
Total Other Current Liabilities
Total Current Liabilities	1.51	1.68	2.04	1.49	0.837
Capital Lease Obligations
Total Long Term Debt
Total Debt
Total Other Liabilities
Total Liabilities	1.6	1.69	2.06	1.52	0.857
Common Stock
Retained Earnings (Accumulated Deficit)
Total Equity	7.62	3.78	11.2	20.1	14.2
Total Liabilities & Shareholders' Equity	9.21	5.47	13.3	21.6	15
Total Common Shares Outstanding